Poulabi Banerjee Selected Research

evinacumab

1/2021	Inhibition of Angiopoietin-Like Protein 3 With Evinacumab in Subjects With High and Severe Hypertriglyceridemia.
1/2020	Evinacumab for Homozygous Familial Hypercholesterolemia.
11/2019	Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Poulabi Banerjee Research Topics

Disease

5	Homozygous Familial Hypercholesterolemia 01/2020 - 03/2018
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2017
2	Acute Coronary Syndrome 01/2022 - 01/2020
2	Hypertriglyceridemia 01/2021 - 01/2019
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2020 - 11/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2017
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2022
1	Unstable Angina 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Ischemic Stroke 01/2020
1	Myocardial Infarction 01/2020
1	Genetic Risk Score 01/2020
1	Rare Diseases (Rare Disease) 11/2019
1	Injection Site Reaction 11/2017
1	Macular Degeneration (Age-Related Maculopathy) 08/2015

Drug/Important Bio-Agent (IBA)

6	alirocumabIBA 01/2022 - 11/2017
4	Proprotein Convertase 9IBA 01/2022 - 03/2018
4	oxidized low density lipoproteinIBA 01/2020 - 01/2017
4	LDL CholesterolIBA 01/2020 - 01/2017
3	evinacumabIBA 01/2021 - 11/2019
3	Monoclonal AntibodiesIBA 01/2020 - 01/2019
3	LipidsIBA 01/2020 - 01/2017
3	LDL Receptors (LDL Receptor)IBA 11/2019 - 11/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2020
2	Atorvastatin (Lipitor)FDA Link 01/2022 - 11/2017
2	Angiopoietin-Like Protein 3IBA 01/2021 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 01/2020 - 01/2019
2	AngiopoietinsIBA 01/2020 - 11/2019
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	ApolipoproteinsIBA 03/2018
1	Ezetimibe (Zetia)FDA Link 11/2017
1	Amyloid beta-PeptidesIBA 08/2015

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
1	Intravenous Infusions 01/2020
1	Precision Medicine 01/2020